Verve Therapeutics is pioneering a new approach to cardiovascular disease care through single-course gene editing medicines.
Base: $71,250 - $187,000; Bonus/Equity: Company bonus eligible; Benefits: Comprehensive program including 401(k), medical, dental, vision
Must-have
Nice-to-have
Must be authorized to work in the US on a full-time basis